NLM Logo

avelumab MeSH Supplementary Concept Data 2022


MeSH Supplementary
avelumab
Unique ID
C000609138
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000609138
Entry Term(s)
MSB-0010682
MSB-0010718C
MSB0010682
MSB0010718C
bavencio
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
KXG2PJ551I
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
330
Note
targets programmed cell death protein-1 ligand; has antineoplastic activity
Source
Cancer Immunol Res. 2015 Oct;3(10):1148-57.
Date of Entry
2016/07/17
Revision Date
2020/07/09
avelumab Preferred
MSB-0010682 Narrower
bavencio Narrower
MSB0010718C Narrower
page delivered in 0.005s